Octiveran (Tenoxicam)

Octiveran (tenoxicam) is employed in conditions that involve inflammatory pain pathways, particularly within the musculoskeletal system.

• Rheumatoid arthritis: reduces joint pain, swelling and stiffness.
• Osteoarthritis: alleviates chronic joint discomfort and improves mobility.
• Ankylosing spondylitis: diminishes spinal inflammation and associated pain.
• Acute musculoskeletal injury: provides short‑term relief of pain and inflammation.
• Post‑operative pain: assists in managing postoperative inflammatory pain.

• Tenoxicam belongs to the oxicam class of NSAIDs and exerts its anti‑inflammatory effect by reversibly inhibiting cyclooxygenase‑1 and cyclooxygenase‑2 enzymes. This inhibition reduces the synthesis of prostaglandins, key mediators of inflammation, pain and fever, thereby providing analgesic and antipyretic activity.

Adverse reactions to tenoxicam may range from mild to severe and should be monitored during therapy.

Common Side Effects

• Gastro‑intestinal discomfort: nausea, dyspepsia or abdominal pain.
• Headache: mild to moderate intensity.
• Dizziness: transient episodes of light‑headedness.
• Skin rash: mild erythema or pruritus.
• Elevated liver enzymes: mild, reversible changes in hepatic function tests.

Serious or Rare Side Effects

• Gastro‑intestinal ulceration or bleeding: may present with hematemesis or melena.
• Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.
• Renal impairment: sudden rise in serum creatinine or reduced urine output.
• Hepatotoxicity: marked elevation of transaminases or jaundice.
• Anaphylaxis: acute, potentially life‑threatening hypersensitivity reaction.

Before initiating therapy with Octiveran, consider the following safety measures:

• Renal function assessment: evaluate baseline kidney function, especially in patients with chronic kidney disease.
• Hepatic monitoring: check liver enzymes prior to treatment and periodically thereafter.
• Gastro‑intestinal risk: assess history of ulcers, bleeding or concurrent NSAID/anticoagulant use.
• Cardiovascular caution: use cautiously in patients with hypertension, heart failure or prior thrombotic events.
• Concomitant medications: review all current drugs for potential interactions.
• Store at ambient temperature: keep below 25°C, retain in original packaging, and protect from moisture.

Tenoxicam can interact with several drug classes, altering efficacy or safety profiles.

Major Interactions (Avoid)

• Anticoagulants (e.g., warfarin): increased risk of serious bleeding.
• Other NSAIDs or COX‑2 inhibitors: heightened gastrointestinal toxicity.
• High‑dose aspirin: additive ulcerogenic effect.

Moderate Interactions (Monitor Closely)

• ACE inhibitors or ARBs: may reduce antihypertensive response and affect renal function.
• Diuretics (loop or thiazide): potential for decreased renal perfusion.
• Lithium: NSAIDs can raise serum lithium levels, risking toxicity.